Dyne Therapeutics
69 hedge funds and large institutions have $615M invested in Dyne Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 13 closing their positions.
146% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 13
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
38% more funds holding
Funds holding: 50 → 69 (+19)
11% more capital invested
Capital invested by funds: $554M → $615M (+$61.1M)
3.95% more ownership
Funds ownership: 60.52% → 64.47% (+4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.16M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.67M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$4.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.58M |
| 2 |
Janus Henderson Group
London,
|
-$7.04M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$4.85M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.04M |
| 5 |
Millennium Management
New York
|
-$3.08M |
DYN Hedge Fund Activity: Q4 2020 in Review
69 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2020, worth a combined $615M — up 11% from $554M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new DYN positions and 13 closed out — a net gain of 19 holders — while 13 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $9.58M sold.
- 69 institutional investors held Dyne Therapeutics (DYN) as of Q4 2020, up from 50 in Q3 2020.
- Funds reported $615M of Dyne Therapeutics stock for Q4 2020, up 11% quarter-over-quarter.
- 32 funds opened new Dyne Therapeutics positions in Q4 2020 and 13 closed out, a net change of +19 holders.
- The largest Dyne Therapeutics buyer in Q4 2020 was BlackRock, an estimated $14.5M added.
- The largest Dyne Therapeutics seller in Q4 2020 was Sectoral Asset Management, an estimated $9.58M sold.
Based on aggregated 13F filings for Q4 2020.